國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

New bioprocessing strategiesdevelopm...

Gottschalk, Uwe.

New bioprocessing strategiesdevelopment and manufacturing of recombinant antibodies and proteins /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	New bioprocessing strategiesedited by Bob Kiss, Uwe Gottschalk, Michael Pohlscheidt.
其他題名:	development and manufacturing of recombinant antibodies and proteins /
其他作者:	Kiss, Bob.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	vi, 469 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Biotechnology.
電子資源:	https://doi.org/10.1007/978-3-319-97110-0
ISBN:	9783319971100$q(electronic bk.)

New bioprocessing strategiesdevelopment and manufacturing of recombinant antibodies and proteins /
New bioprocessing strategiesdevelopment and manufacturing of recombinant antibodies and proteins /[electronic resource] :edited by Bob Kiss, Uwe Gottschalk, Michael Pohlscheidt. - Cham :Springer International Publishing :2018. - vi, 469 p. :ill. (some col.), digital ;24 cm. - Advances in biochemical engineering/biotechnology,1650724-6145 ;. - Advances in biochemical engineering/biotechnology ;138..

Market and Capacity evolvement of the Biopharmaceutical Industry -- New Mammalian Expression Systems -- Innovation in seed train cultivation and production culture -- Manufacturing of Proteins and Antibodies / Risk mitigation for the contamination by adventitious agents -- Harvest operations -- Downstream Processing Technologies / Capturing and Final Purifaction -- Fully disposable manufacturing concepts for clinical and commercial manufacturing and Ballroom Concepts -- Augmented Reality - PAT and Artificial Intelligence for innovative process monitoring and controls -- Trends and innovations in formulations, fill and finish technologies and drug delivery -- Process Integration towards continuous manufacturing -- Future direction of Manufacturing of novel molecular format - a research perspective (bispecific antibodies, ADC, Ab fragments, fusion proteins, etc -- Cell therapy manufacturing for modern therapeutics -- Gene therapy -- Modern technologies and strategies for vaccine manufacturing -- Product and Technology Lifecycle Management in the Pharmaceutical Industry -- Integrated High Throughput Development -- A different perspective - How much innovation is really needed for production of mAb by mammalian cell technology?

This book review series presents current trends in modern biotechnology. The aim is to cover all aspects of this interdisciplinary technology where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science. Volumes are organized topically and provide a comprehensive discussion of developments in the respective field over the past 3-5 years. The series also discusses new discoveries and applications. Special volumes are dedicated to selected topics which focus on new biotechnological products and new processes for their synthesis and purification. In general, special volumes are edited by well-known guest editors. The series editor and publisher will however always be pleased to receive suggestions and supplementary information. Manuscripts are accepted in English.

ISBN: 9783319971100$q(electronic bk.)

Standard No.: 10.1007/978-3-319-97110-0doiSubjects--Topical Terms:

188829
Biotechnology.

LC Class. No.: TP248.2 / .N493 2018

Dewey Class. No.: 660.6

New bioprocessing strategiesdevelopment and manufacturing of recombinant antibodies and proteins /
LDR:03257nmm a2200337 a 4500 001 546694
003 DE-He213
005 20190509144154.0
006 m d
007 cr nn 008maaau
008 190627s2018 gw s 0 eng d
020 $a 9783319971100$q(electronic bk.)
020 $a 9783319971087$q(paper)
024 7 $a 10.1007/978-3-319-97110-0 $2 doi
035 $a 978-3-319-97110-0
040 $a GP $c GP
041 0 $a eng
050 4 $a TP248.2 $b .N493 2018
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 660.6 $2 23
090 $a TP248.2 $b .N532 2018
245 0 0 $a New bioprocessing strategies $h [electronic resource] : $b development and manufacturing of recombinant antibodies and proteins / $c edited by Bob Kiss, Uwe Gottschalk, Michael Pohlscheidt.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a vi, 469 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in biochemical engineering/biotechnology, $x 0724-6145 ; $v 165
505 0 $a Market and Capacity evolvement of the Biopharmaceutical Industry -- New Mammalian Expression Systems -- Innovation in seed train cultivation and production culture -- Manufacturing of Proteins and Antibodies / Risk mitigation for the contamination by adventitious agents -- Harvest operations -- Downstream Processing Technologies / Capturing and Final Purifaction -- Fully disposable manufacturing concepts for clinical and commercial manufacturing and Ballroom Concepts -- Augmented Reality - PAT and Artificial Intelligence for innovative process monitoring and controls -- Trends and innovations in formulations, fill and finish technologies and drug delivery -- Process Integration towards continuous manufacturing -- Future direction of Manufacturing of novel molecular format - a research perspective (bispecific antibodies, ADC, Ab fragments, fusion proteins, etc -- Cell therapy manufacturing for modern therapeutics -- Gene therapy -- Modern technologies and strategies for vaccine manufacturing -- Product and Technology Lifecycle Management in the Pharmaceutical Industry -- Integrated High Throughput Development -- A different perspective - How much innovation is really needed for production of mAb by mammalian cell technology?
520 $a This book review series presents current trends in modern biotechnology. The aim is to cover all aspects of this interdisciplinary technology where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science. Volumes are organized topically and provide a comprehensive discussion of developments in the respective field over the past 3-5 years. The series also discusses new discoveries and applications. Special volumes are dedicated to selected topics which focus on new biotechnological products and new processes for their synthesis and purification. In general, special volumes are edited by well-known guest editors. The series editor and publisher will however always be pleased to receive suggestions and supplementary information. Manuscripts are accepted in English.
650 0 $a Biotechnology. $3 188829
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Medicinal Chemistry. $3 275183
700 1 $a Kiss, Bob. $3 825695
700 1 $a Gottschalk, Uwe. $3 490678
700 1 $a Pohlscheidt, Michael. $3 825696
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in biochemical engineering/biotechnology ; $v 138. $3 677812
856 4 0 $u https://doi.org/10.1007/978-3-319-97110-0
950 $a Chemistry and Materials Science (Springer-11644)